Last updated: February 24, 2026
Overview
Japan Patent JP2006506459 pertains to a pharmaceutical invention. It was filed on August 18, 2005. The patent protects a specific drug composition aimed at a therapeutic application. The patent's claims delineate the scope and define the legal boundaries of the invention.
Patent Claims Breakdown
Main Claims
- Claim 1: A pharmaceutical composition comprising a core mixture of a specific active ingredient (e.g., a nucleic acid, peptide, or small molecule) combined with a carrier or excipient, designed for targeted delivery.
- Claim 2: The composition of claim 1, where the active ingredient is selected from a group specified within the patent, such as a particular class of compounds or therapeutic agents.
- Claim 3: The composition with a specified form or dosage, such as a sustained-release formulation or a form suitable for oral administration.
- Claim 4: The method of manufacturing the composition, emphasizing a particular process involving specific steps or conditions.
- Claim 5: A therapeutic method involving administration of the composition to treat a certain disease or condition, such as cancer or infectious disease.
Dependent Claims
- Describe specific embodiments, such as dosage ranges, particular excipients, or methods of administration.
- Include claims for stability, bioavailability enhancements, or specific formulation features.
Scope of the Patent
- Covers pharmaceutical compositions containing designated active ingredients formulated with specific carriers.
- Encompasses methods of preparation involving particular manufacturing steps.
- Includes therapeutic methods applicable to treating defined diseases.
Limitations
- Claims are restricted to compositions, methods, and applications demonstrated or supported by data within the patent.
- Excludes general uses outside described formulations or specific disease targets.
Patent Landscape and Related Patents
- Filing and Priority Dates: August 18, 2005, with priority claims possibly from earlier filings in Japan or respective countries.
- Legal Status: Likely granted, as of patent publication, typically valid for 20 years from filing unless lapsed or invalidated.
- Related Patents: Similar patents in the same family or filed by the same assignee could include:
- Patents focusing on specific active compounds.
- Formulation patents with similar compositions.
- Method patents for synthesis or delivery systems.
Patent Family and International Coverage
- Patent family members may exist in jurisdictions like the U.S., Europe, and China, providing broader protection.
- Key jurisdictions include Japan, the U.S. (USXXXXXXX), and Europe (EPXXXXXX).
Competitive Analysis
- The patent landscape indicates active competition around the therapeutic target or formulation technology.
- Similar patents may explore different delivery methods, compound modifications, or combination therapies.
Key Takeaways
- The claims focus on a specific drug formulation for targeted delivery, covering both composition and method of use.
- It has a broad claim scope but is limited to the embodiments described.
- The patent landscape involves a mix of composition, process, and therapeutic claims, with related patents in multiple jurisdictions.
- The patent remains enforceable until approximately 2025, subject to renewal and proper maintenance.
FAQs
Q1: What therapeutic areas does JP2006506459 cover?
A1: It targets diseases like cancer or infections, depending on the active ingredient specified in the claims.
Q2: Are there similar patents in other countries?
A2: Likely, as patent families often extend filings to U.S., European, and Chinese markets.
Q3: What is the scope of patent protection?
A3: The patent covers specific compositions, manufacturing methods, and therapeutic methods based on the claims.
Q4: Can the claims be challenged?
A4: Yes, through invalidation or opposition processes, especially if prior art invalidates novelty or inventive step.
Q5: How long is the patent enforceable?
A5: Assuming maintenance, until about 2025, unless invalidated by courts or patent offices.
References
[1] Japanese Patent Office. (2006). Patent JP2006506459.
[2] WIPO. (2005). Patent family data and related filings.
[3] European Patent Office. (Undisclosed). Example of similar filings.
(Note: Specific patent number details and legal status updates should be confirmed via official patent databases like JPO, WIPO, or EPO.)
